Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Equity (2020 - 2025)

Historic Return on Equity for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to 136.86%.

  • Biodesix's Return on Equity rose 1382200.0% to 136.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 136.86%, marking a year-over-year increase of 1382200.0%. This contributed to the annual value of 3.36% for FY2024, which is 6800.0% up from last year.
  • Biodesix's Return on Equity amounted to 136.86% in Q3 2025, which was up 1382200.0% from 6.8% recorded in Q2 2025.
  • Biodesix's 5-year Return on Equity high stood at 136.86% for Q3 2025, and its period low was 32.47% during Q4 2023.
  • Moreover, its 5-year median value for Return on Equity was 2.51% (2025), whereas its average is 10.58%.
  • Data for Biodesix's Return on Equity shows a peak YoY increase of 1382200bps (in 2025) and a maximum YoY decrease of -1015600bps (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Biodesix's Return on Equity stood at 2.54% in 2021, then tumbled by -161bps to 6.63% in 2022, then crashed by -390bps to 32.47% in 2023, then soared by 95bps to 1.75% in 2024, then skyrocketed by 7900bps to 136.86% in 2025.
  • Its Return on Equity stands at 136.86% for Q3 2025, versus 6.8% for Q2 2025 and 2.51% for Q1 2025.